Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of California, Los Angeles
Study ID
NCT06370780
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • EPI LOVE — OTHER
    Observational cohort only

Study Details

Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.

Key Dates

Start date
Feb 9, 2024
Status verified
Sep 2025
Primary completion
Apr 30, 2028
Completion
Apr 30, 2028

Study Design

Enrollment
1,000 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Other: Download the REMAIN App
    All participants download the app

Primary Outcome Measure

Incidence of HIV Viral Suppression [ Time Frame: past 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, Los AngelesLos AngelesCalifornia90095
Pamina Gorbach, DrPh, MHS
[email protected]
(628) 226-1863
Valerie El-Alfi, MA
[email protected]

Find similar trials in Los Angeles, CA

By condition
HIV
By specialty
Infectious disease
By research site
University of California, Los Angeles· Los Angeles, CA

Related Studies